课题基金 / 基金详情

Spectroscopic Studies of Molybdoenzymes and Models

Spectroscopic Studies of Molybdoenzymes and Models
钼酶和模型的光谱研究
批准号:
7195192
负责人:
MARTIN L KIRK
金额:
$27.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-01 至 2010-12-31

项目摘要

项目成果

MARTIN L KIRK的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):拟议研究的广泛,长期目标是了解pyranopterin钼酶的几何和电子结构对功能的贡献,特别是与理解黄嘌呤氧化酶,醛氧化酶和亚硫酸盐氧化酶的活性机制相关,因为这些是人类发现的关键酶。提出的研究计划的具体目标是:1)全面了解黄嘌呤氧化酶(XO)的还原半反应;2)利用XO相关一氧化碳脱氢酶(CODH)活性位点的小分子类似物来了解电子结构对催化的贡献;3)关联电子和几何结构对亚硫酸盐氧化酶(SO)氧原子和电子转移反应活性的贡献。4)确定DMSO还原酶位点对称对酶催化的贡献。患有钼辅助因子缺乏症的个体表现出严重的神经系统症状和幼儿死亡。XO的生理功能似乎相当复杂,最近有研究表明,XO在先天免疫系统的功能和缺血再灌注损伤中发挥核心作用。AO和XO最近都与药物前活化、药物代谢以及在特定条件下的NO合成酶活性有关。与XO相比,我们对AO的病理生理相关性知之甚少。然而,AO催化磺胺类药物的减少,抗癌前药的激活,并且最近被证明将泛环洛韦代谢为强效抗病毒药物喷昔洛韦,这已被发现对诸如单纯疱疹、水痘带状疱疹、eb和乙肝等病毒感染有效。在脊椎动物中,SO存在于线粒体中!膜间空间,其中亚硫酸盐在生理上重要的氧化是半胱氨酸和蛋氨酸氧化降解的最后一步。该研究计划将利用结合的光谱方法,辅以计算研究,对模型和酶进行详细的活性位点电子结构描述,以及这种电子结构如何促进其活性机制。钼酶对人体健康至关重要。我们对它们在药物代谢、自由基损伤和免疫系统中的作用的新认识强调了它们在各种健康相关问题中的作用。
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objectives of the proposed research are to understand geometric and electronic structure contributions to the function of pyranopterin molybdenum enzymes, with particular relevance to understanding the mechanism of activity in xanthine oxidase, aldehyde oxidase and sulfite oxidase as these are key enzymes found in humans. The specific aims of the proposed research plan are to 1) develop a comprehensive understanding of the reductive half-reaction in xanthine oxidase (XO), 2) use small molecule analogues of the XO related carbon monoxide dehydrogenase (CODH) active site to understand electronic structure contributions to catalysis, 3) correlate electronic and geometric structure contributions to oxygen atom and electron transfer reactivity in sulfite oxidase (SO), and 4) determine how the DMSO reductase site symmetry contributes to enzymatic catalysis. Individuals suffering from molybdenum cofactor deficiency display severe neurological symptoms and early childhood death. The physiological function of XO appears to be quite complex, and is exemplified by the fact that XO has recently been suggested to play a central role in the function of the innate immune system, and in postischemic reperfusion injury. Both AO and XO have recently been implicated in pro-drug activation, drug metabolism and, under specific conditions, NO synthase activity. Compared to XO, very little is known concerning the full pathophysiological relevance of AO. However, AO catalyzes the reduction of sulfa drugs, the activation of anticancer prodrugs, and has recently been shown to metabolize famciclovir to the potent antiviral penciclovir, which has been found to be effective against such viral infections as herpes simplex, varicella zoster, Epstein-Barr, and hepatitis B. In vertebrates, SO is found in the mitochondria! intermembrane space where the physiologically important oxidation of sulfite represents the terminal step in the oxidative degradation of cysteine and methionine. The research plan will utilize a combined spectroscopic approach, complimented by computational studies, on both models and enzymes to develop a detailed electronic structure description of the active site and how this electronic structure contributes to their mechanism of activity. Molybdenum enzymes are of key importance to human health. Our emerging understanding of their role in drug metabolism, free-radical damage, and the immune system underscore their role in a variety of health related issues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
XAS STUDIES OF THE THIOLATE LIGAND DONORS IN MODELS OF THE SULFITE OXIDASE ACTIV
  • 批准号:
    7597960
  • 项目类别:
  • 资助金额:
    $0.02万
  • 财政年份:
    2007
  • 负责人:
    MARTIN L KIRK
  • 依托单位:
XAS STUDIES OF THE THIOLATE LIGAND DONORS IN MODELS OF THE SULFITE OXIDASE ACTIV
  • 批准号:
    7370433
  • 项目类别:
  • 资助金额:
    $0.02万
  • 财政年份:
    2006
  • 负责人:
    MARTIN L KIRK
  • 依托单位:
XAS STUDIES OF CPD I INTERMEDIATES
  • 批准号:
    6658769
  • 项目类别:
  • 资助金额:
    $14.32万
  • 财政年份:
    2002
  • 负责人:
    MARTIN L KIRK
  • 依托单位:
XAS STUDIES OF CPD I INTERMEDIATES
  • 批准号:
    6586802
  • 项目类别:
  • 资助金额:
    $14.32万
  • 财政年份:
    2002
  • 负责人:
    MARTIN L KIRK
  • 依托单位:
海外基金